natural alternatives for AFB control. Thus, the aim was to analyze the effects of honeybee venom on P. larvae growth as well as its effect on adult bee survival after chronic exposure to BV. P. larvae strains had been isolated from larvae with AFB from four apiaries in Argentina and PL33 (UB-CIDEFI) like reference strain. All strains were genotypically identified using PL2-Fw and PL2-Rv primers, and characterized like ERIC I with ERIC1R -and ERIC2 primers (Genersch et al. 2006) .
For BV extraction, A. mellifera forager bees were obtained by covering the hive entrance and collecting them in their back flight. Venom sacs were dissected by pulling the sting apparatus from 30 bees. The resultant droplet of BV from the tip of the sting was placed on sterile slides, allowed to dry in dark for 24 h, were collected by scraping and then weighed.
P. larvae isolates were exposed to serial dilutions of BV. One hundred microliters of Mueller-Hinton broth, yeast extract, and thiamine broth (Gende et al. 2008) were placed per well. BV stock solution and 50 μL of the bacterial suspension (0.5 McFarland scale) were added to each well (serial dilutions from 200 to 1.56 μg/mL). Incubation took place at 37ºC for 48 h. The inhibition of bacterial growth was confirmed by resazurin method (Damiani et al. 2014) . Serial dilutions from 100 to 0.04 μg/mL of oxytetracycline (Fluka Analytical) were included as a positive control (Alippi et al. 2007 ). The lowest concentration of each substance that showed inhibition was considered as the minimal inhibitory concentration (MIC). The minimal bactericidal concentration (MBC) was estimated transferring 100 μL from MIC negative wells to plates with MuellerHinton broth, yeast extract, glucose, and sodium pyruvate agar, and incubated at 37°C for 48 h. Treatments were tested in triplicate. Statistical analyses were conducted in R 2.13.0 (R Development Core Team 2011). Linear mixed-model was performed to determine if MIC and MBC values varied due to treatments and strains (as random effect). Linear mixed effect models were fitted using maximum likelihood with nlme package.
The BV chronic toxicity was evaluated maintaining adult bees under short-term consumption. Newly emerged bees from capped brood combs were confined. Three replicates of 25 bees were supplied ad libitum these diets: 0; 100; 500; and 1,000 μg/mL of BV powder in sugar syrup 60 % (w/v), and were replaced daily. Survival curves plotting the number of live bees per group versus time were made. The Gehan-Breslow nonparametric test was performed to determine significant differences in survival curves. Pairwise multiple comparisons were made with the Holm-Sidak method (α=0.05). Table I shows MIC and MBC values for BV and oxytetracycline against the bacterial strains. Strains responded significantly different to the treatments (MIC: t=4.01; df=20; P=0.0007; and MBC: t=3.74; df=20; P=0.0013). From the random effect analysis significant differences among strains were not detected in each individual treatment. Furthermore, oral ingestion of BV did not cause significant mortality of adult bees (χ 2 =3.831; df=3; P=0.28; Fig. 1 ). As an alternative to the burning of infected hives, antibiotic oxytetracycline is currently used in AFB control in honeybee colonies. However, its intensive use resulted in oxytetracycline-resistant P. larvae isolates (Alippi et al. 2007; Evans 2003) . In previous years, some natural substances have been tried as unconventional treatments for this disease. We report the results of the first study on the potential use of BV as an antimicrobial agent for AFB control. Results indicate that BV had in vitro activity against P. larvae vegetative cells, requiring very low concentrations to inhibit its growth (MIC values from 3.12 to 8.33 μg/mL). The BV was a 12-and 50-fold better antimicrobial than essential oils (Gende et al. 2008 ) and botanical extracts (Damiani et al. 2014) , respectively.
Indeed, as BV is present on the cuticle of adult bees and on comb wax, it may act as a social antiseptic device (Baracchi and Turillazzi 2010) . Lytic antibacterial and bacteriostatic activity against Gram-negative and Gram-positive bacteria has been reported for some peptides from BV and refused for others (Baracchi et al. 2013; Li et al. 2006; Van Vaerenbergh et al. 2013) . Furthermore, the mode of action for BV against Gram-positive bacteria needs to be understood in order to determine its potential value as a natural treatment of AFB.
More studies are needed to confirm these promising findings. For example, exposure bioassays of infected larvae to different BV doses or doses of single antimicrobial peptides from BV are a reliable approach to determine possible changes in the midgut environment that might inhibit P. larvae growth. This research also constitutes the first record of oral administration of BV to an invertebrate biological model. No lethal or behavioral effects on bees after a week of ingesting BV were revealed. High doses of BV proved much less toxic for bees than some botanical extracts (Damiani et al. 2014) . Further studies should be conducted to determine the toxicological risks and the optimum dosage of BV or the use of single antimicrobial peptides (i.e., Melittin) for field assays. BV extraction has become a standardized practice, characterized for being safe, simple, and causing no harm to bees. It would be interesting to investigate its effect on other apicultural diseases.
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